1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow ABI-5366: new trials by email Literature Review of ABI-5366 trials Research Report on ABI-5366
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes ABI-5366, ABI-5366 Placebo - Recurrent Genital Herpes Simplex Type 2 | Phase 1 | Completed | Assembly Biosciences | 115 | 2024-05-30 | 2026-03-30 |
Herpes Genitalis (1)
Australia (1) · New Zealand (1)